Fetal membranes: Potential source of preterm birth biomarkers

Ramkumar Menon, Nathalia Noda Nicolau, Sarah Bredson, Jossimara Polettini

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Citations (Scopus)

Abstract

Preterm birth (birth before 37 weeks of complete gestation) is a major pregnancy complication and is the second largest cause of neonatal mortality worldwide. Majority of the preterm births are due to unknown etiologies, and this class of preterm births is known as spontaneous preterm birth (PTB). There are no reliable biomarkers to predict PTB as its causality and pathophysiologic pathways are unclear. Various maternal and fetal intrauterine compartments produce biomarkers that are associated with PTB. However, screening and diagnosis of PTB is difficult due to the overlap between various pathologic events associated with PTB and heterogeneity in biomarker response. Several studies have contributed to our current understanding of the mechanistic role of biomarkers produced by maternal and fetal tissues, but none of them have emerged as diagnostic tools. This chapter reviews knowledge gaps in PTB biomarker literature and discusses some of the fundamental issues associated with biomarker research in PTB. This discussion is based on data generated using human fetal membranes. Fetal membranes (amniochorionic membranes) are fetally derived tissues and forms the innermost lining of the intra-amniotic cavity. They provide structural integrity to the intrauterine cavity and are capable of responding to various maternal-fetal physiologic and pathophysiologic signals. Reports document hundreds of biomarkers produced by fetal membranes that are associated with various pregnancy complications. However, fetal membrane biomarker response is complex, and the diversity in their response makes it difficult to understand the pathways of PTB. This chapter reviews three distinct scenarios where fetal membrane biomarker signature can vary: (1) type of antigen, (2) type of risk exposure, and (3) the race/ethnicity of the subject from which the membranes are derived. This is to highlight the heterogeneity in fetal membrane biomarkers and demonstrate how pathways can be different based on distinct biomarker signature. Understanding both maternal and fetal biomarker response based on an individual's own risk profile is needed to tailor interventions to reduce the risk of PTB.

Original languageEnglish (US)
Title of host publicationGeneral Methods in Biomarker Research and their Applications
PublisherSpringer International Publishing
Pages483-529
Number of pages47
Volume1-2
ISBN (Print)9789400776968, 9789400776951
DOIs
StatePublished - Sep 2 2015

Fingerprint

Extraembryonic Membranes
Premature Birth
Membrane Potentials
Biomarkers
Mothers
Pregnancy Complications
Membranes
Infant Mortality
Causality
Fetus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Menon, R., Nicolau, N. N., Bredson, S., & Polettini, J. (2015). Fetal membranes: Potential source of preterm birth biomarkers. In General Methods in Biomarker Research and their Applications (Vol. 1-2, pp. 483-529). Springer International Publishing. https://doi.org/10.1007/978-94-007-7696-8_28

Fetal membranes : Potential source of preterm birth biomarkers. / Menon, Ramkumar; Nicolau, Nathalia Noda; Bredson, Sarah; Polettini, Jossimara.

General Methods in Biomarker Research and their Applications. Vol. 1-2 Springer International Publishing, 2015. p. 483-529.

Research output: Chapter in Book/Report/Conference proceedingChapter

Menon, R, Nicolau, NN, Bredson, S & Polettini, J 2015, Fetal membranes: Potential source of preterm birth biomarkers. in General Methods in Biomarker Research and their Applications. vol. 1-2, Springer International Publishing, pp. 483-529. https://doi.org/10.1007/978-94-007-7696-8_28
Menon R, Nicolau NN, Bredson S, Polettini J. Fetal membranes: Potential source of preterm birth biomarkers. In General Methods in Biomarker Research and their Applications. Vol. 1-2. Springer International Publishing. 2015. p. 483-529 https://doi.org/10.1007/978-94-007-7696-8_28
Menon, Ramkumar ; Nicolau, Nathalia Noda ; Bredson, Sarah ; Polettini, Jossimara. / Fetal membranes : Potential source of preterm birth biomarkers. General Methods in Biomarker Research and their Applications. Vol. 1-2 Springer International Publishing, 2015. pp. 483-529
@inbook{3eb0b7ba9b594b5099bd9d753806b8a3,
title = "Fetal membranes: Potential source of preterm birth biomarkers",
abstract = "Preterm birth (birth before 37 weeks of complete gestation) is a major pregnancy complication and is the second largest cause of neonatal mortality worldwide. Majority of the preterm births are due to unknown etiologies, and this class of preterm births is known as spontaneous preterm birth (PTB). There are no reliable biomarkers to predict PTB as its causality and pathophysiologic pathways are unclear. Various maternal and fetal intrauterine compartments produce biomarkers that are associated with PTB. However, screening and diagnosis of PTB is difficult due to the overlap between various pathologic events associated with PTB and heterogeneity in biomarker response. Several studies have contributed to our current understanding of the mechanistic role of biomarkers produced by maternal and fetal tissues, but none of them have emerged as diagnostic tools. This chapter reviews knowledge gaps in PTB biomarker literature and discusses some of the fundamental issues associated with biomarker research in PTB. This discussion is based on data generated using human fetal membranes. Fetal membranes (amniochorionic membranes) are fetally derived tissues and forms the innermost lining of the intra-amniotic cavity. They provide structural integrity to the intrauterine cavity and are capable of responding to various maternal-fetal physiologic and pathophysiologic signals. Reports document hundreds of biomarkers produced by fetal membranes that are associated with various pregnancy complications. However, fetal membrane biomarker response is complex, and the diversity in their response makes it difficult to understand the pathways of PTB. This chapter reviews three distinct scenarios where fetal membrane biomarker signature can vary: (1) type of antigen, (2) type of risk exposure, and (3) the race/ethnicity of the subject from which the membranes are derived. This is to highlight the heterogeneity in fetal membrane biomarkers and demonstrate how pathways can be different based on distinct biomarker signature. Understanding both maternal and fetal biomarker response based on an individual's own risk profile is needed to tailor interventions to reduce the risk of PTB.",
author = "Ramkumar Menon and Nicolau, {Nathalia Noda} and Sarah Bredson and Jossimara Polettini",
year = "2015",
month = "9",
day = "2",
doi = "10.1007/978-94-007-7696-8_28",
language = "English (US)",
isbn = "9789400776968",
volume = "1-2",
pages = "483--529",
booktitle = "General Methods in Biomarker Research and their Applications",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Fetal membranes

T2 - Potential source of preterm birth biomarkers

AU - Menon, Ramkumar

AU - Nicolau, Nathalia Noda

AU - Bredson, Sarah

AU - Polettini, Jossimara

PY - 2015/9/2

Y1 - 2015/9/2

N2 - Preterm birth (birth before 37 weeks of complete gestation) is a major pregnancy complication and is the second largest cause of neonatal mortality worldwide. Majority of the preterm births are due to unknown etiologies, and this class of preterm births is known as spontaneous preterm birth (PTB). There are no reliable biomarkers to predict PTB as its causality and pathophysiologic pathways are unclear. Various maternal and fetal intrauterine compartments produce biomarkers that are associated with PTB. However, screening and diagnosis of PTB is difficult due to the overlap between various pathologic events associated with PTB and heterogeneity in biomarker response. Several studies have contributed to our current understanding of the mechanistic role of biomarkers produced by maternal and fetal tissues, but none of them have emerged as diagnostic tools. This chapter reviews knowledge gaps in PTB biomarker literature and discusses some of the fundamental issues associated with biomarker research in PTB. This discussion is based on data generated using human fetal membranes. Fetal membranes (amniochorionic membranes) are fetally derived tissues and forms the innermost lining of the intra-amniotic cavity. They provide structural integrity to the intrauterine cavity and are capable of responding to various maternal-fetal physiologic and pathophysiologic signals. Reports document hundreds of biomarkers produced by fetal membranes that are associated with various pregnancy complications. However, fetal membrane biomarker response is complex, and the diversity in their response makes it difficult to understand the pathways of PTB. This chapter reviews three distinct scenarios where fetal membrane biomarker signature can vary: (1) type of antigen, (2) type of risk exposure, and (3) the race/ethnicity of the subject from which the membranes are derived. This is to highlight the heterogeneity in fetal membrane biomarkers and demonstrate how pathways can be different based on distinct biomarker signature. Understanding both maternal and fetal biomarker response based on an individual's own risk profile is needed to tailor interventions to reduce the risk of PTB.

AB - Preterm birth (birth before 37 weeks of complete gestation) is a major pregnancy complication and is the second largest cause of neonatal mortality worldwide. Majority of the preterm births are due to unknown etiologies, and this class of preterm births is known as spontaneous preterm birth (PTB). There are no reliable biomarkers to predict PTB as its causality and pathophysiologic pathways are unclear. Various maternal and fetal intrauterine compartments produce biomarkers that are associated with PTB. However, screening and diagnosis of PTB is difficult due to the overlap between various pathologic events associated with PTB and heterogeneity in biomarker response. Several studies have contributed to our current understanding of the mechanistic role of biomarkers produced by maternal and fetal tissues, but none of them have emerged as diagnostic tools. This chapter reviews knowledge gaps in PTB biomarker literature and discusses some of the fundamental issues associated with biomarker research in PTB. This discussion is based on data generated using human fetal membranes. Fetal membranes (amniochorionic membranes) are fetally derived tissues and forms the innermost lining of the intra-amniotic cavity. They provide structural integrity to the intrauterine cavity and are capable of responding to various maternal-fetal physiologic and pathophysiologic signals. Reports document hundreds of biomarkers produced by fetal membranes that are associated with various pregnancy complications. However, fetal membrane biomarker response is complex, and the diversity in their response makes it difficult to understand the pathways of PTB. This chapter reviews three distinct scenarios where fetal membrane biomarker signature can vary: (1) type of antigen, (2) type of risk exposure, and (3) the race/ethnicity of the subject from which the membranes are derived. This is to highlight the heterogeneity in fetal membrane biomarkers and demonstrate how pathways can be different based on distinct biomarker signature. Understanding both maternal and fetal biomarker response based on an individual's own risk profile is needed to tailor interventions to reduce the risk of PTB.

UR - http://www.scopus.com/inward/record.url?scp=84958696171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958696171&partnerID=8YFLogxK

U2 - 10.1007/978-94-007-7696-8_28

DO - 10.1007/978-94-007-7696-8_28

M3 - Chapter

AN - SCOPUS:84958696171

SN - 9789400776968

SN - 9789400776951

VL - 1-2

SP - 483

EP - 529

BT - General Methods in Biomarker Research and their Applications

PB - Springer International Publishing

ER -